- Home
- PAVS vs MDXH Comparison
PAVS vs MDXH Comparison
Compare PAVS & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- MDXH
- Stock Information
- Founded
- PAVS 2004
- MDXH 2003
- Country
- PAVS United States
- MDXH Belgium
- Employees
- PAVS N/A
- MDXH N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- MDXH
- Sector
- PAVS Health Care
- MDXH
- Exchange
- PAVS Nasdaq
- MDXH Nasdaq
- Market Cap
- PAVS 49.1M
- MDXH 141.1M
- IPO Year
- PAVS 2019
- MDXH 2021
- Fundamental
- Price
- PAVS $0.87
- MDXH $3.72
- Analyst Decision
- PAVS
- MDXH Buy
- Analyst Count
- PAVS 0
- MDXH 1
- Target Price
- PAVS N/A
- MDXH $6.00
- AVG Volume (30 Days)
- PAVS 147.1K
- MDXH 167.9K
- Earning Date
- PAVS 08-04-2025
- MDXH 11-05-2025
- Dividend Yield
- PAVS N/A
- MDXH N/A
- EPS Growth
- PAVS N/A
- MDXH N/A
- EPS
- PAVS N/A
- MDXH N/A
- Revenue
- PAVS $71,542.00
- MDXH $98,953,000.00
- Revenue This Year
- PAVS N/A
- MDXH $24.77
- Revenue Next Year
- PAVS N/A
- MDXH $22.21
- P/E Ratio
- PAVS N/A
- MDXH N/A
- Revenue Growth
- PAVS N/A
- MDXH 22.56
- 52 Week Low
- PAVS $0.32
- MDXH $1.35
- 52 Week High
- PAVS $1.50
- MDXH $3.91
- Technical
- Relative Strength Index (RSI)
- PAVS 56.78
- MDXH 65.06
- Support Level
- PAVS $0.76
- MDXH $3.46
- Resistance Level
- PAVS $0.90
- MDXH $3.80
- Average True Range (ATR)
- PAVS 0.12
- MDXH 0.16
- MACD
- PAVS 0.01
- MDXH -0.01
- Stochastic Oscillator
- PAVS 47.73
- MDXH 58.70
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.